Trial: 202203192

A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors

Phase

III (Cancer Control)

Principal Investigator

Van Tine, Brian

Disease Site

Soft Tissue

Learn more about this study at: clinicaltrials.gov